Target intelligence / Profile preview

Akirin-2 pseudogene 1 (AKIRIN2P1)

Target
AKIRIN2P1
Molecular classification
Other (Pseudogene)
01

Overview

Akirin-2 pseudogene 1 (AKIRIN2P1) is a non-protein-coding sequence in the human genome classified as a pseudogene related to *Akirin2*. Pseudogenes result from gene duplication or retrotransposition events and typically do not produce functional protein products. There are no established biological activities, disease associations, or drug interactions for AKIRIN2P1. All described biological and therapeutic roles pertain to the functional gene Akirin2, not its pseudogenes.

Other names
AKIRIN2P1Akirin-2 pseudogene 1

Beyond the preview

Go deeper on Akirin-2 pseudogene 1 (AKIRIN2P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Akirin-2 pseudogene 1 (AKIRIN2P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call